Nuvo Pharmaceuticals Inc NRIFF

Daydream

[blackascanbe]

I can only hope that the institutional investors look at management's record. Taking a debt laden biotech from certain bankruptcy to a company with an FDA approved drug, licensed distribution to a multinational multi billion dollar corporation , 35  million dollars in the bank with no debt and having attracted a roster of leading pain medication specialists, with a pipeline of other potential blockbuster drugs.I'd say that was the kind of management that knew what to do. The share price will eventually take care of itself, in spite of sellers like consultant99 adding to the pressure on the stock. He's complaining about the share price but is the very example of why it has declined.